🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Sherika Hanley

Durban University of Technology

ORCID: 0000-0002-4343-7646

Also affiliated with University of KwaZulu-Natal

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 13 papers. Top paper: “Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial”.

Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial

The Lancet(2021)10.1016/s0140-6736(21)00314-7
N/A
5.5DataRank · unranked
162 citations

Sean S. Brummel, Lauren Ziemba, Lynda Stranix‐Chibanda, Katie McCarthy, Anne Coletti +39 more

Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial

The Lancet HIV(2023)10.1016/s2352-3018(23)00061-9
N/A
1.1DataRank · unranked
30 citations

Lauren Ziemba, Sean S. Brummel, Katie McCarthy, Anne Coletti, Chelsea Krotje +95 more

Safety and pharmacokinetics of oral and long-acting injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study

The Lancet HIV(2024)10.1016/s2352-3018(23)00300-4
N/A
1.1DataRank · unranked
29 citations

Edmund V. Capparelli, Katherine Calabrese, Kristin Baltrusaitis, Mark A. Marzinke, Cynthia McCoig +36 more

Acceptability and tolerability of long-acting injectable cabotegravir or rilpivirine in the first cohort of virologically suppressed adolescents living with HIV (IMPAACT 2017/MOCHA): a secondary analysis of a phase 1/2, multicentre, open-label, non-comparative dose-finding study

The Lancet HIV(2024)10.1016/s2352-3018(23)00301-6
N/A
0.959DataRank · unranked
26 citations

Jennifer Chapman, Rachel Ohrenschall, Katherine Calabrese, Kristin Baltrusaitis, Barbara Heckman +32 more

Obesity in young South African women living with HIV: A cross-sectional analysis of risk factors for cardiovascular disease

PLoS ONE(2021)10.1371/journal.pone.0255652
N/A
0.564DataRank · unranked
42 citations

Dhayendre Moodley, Mergan Naidoo, Sherika Hanley

Safety of combined long-acting injectable cabotegravir and long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study

The Lancet HIV(2025)10.1016/s2352-3018(24)00344-8
N/A
0.535DataRank · unranked
12 citations

Kristin Baltrusaitis, Brookie M. Best, Jack Moye, Ellen Townley, Avy Violari +36 more

MEDICINE AND THE LAW

South African Medical Journal(2022)10.7196/samj.2022.v112i10.16596
N/A
0.406DataRank · unranked
14 citations

Sherika Hanley, V Bangalee, Avania Bangalee

Unintended pregnancy and contraception use among African women living with HIV: Baseline analysis of the multi-country US PEPFAR PROMOTE cohort

PLoS ONE(2024)10.1371/journal.pone.0290285
N/A
0.280DataRank · unranked
5 citations

Nonhlanhla Yende‐Zuma, Sherika Hanley, Teacler Nematadzira, Mandisa Nyati, Sufia Dadabhai +6 more

Perceptions of women enrolled in a cardiovascular disease screening and prevention in HIV study

South African Family Practice(2023)10.4102/safp.v65i1.5554
N/A
0DataRank · unranked
0 citations

Galaletsang J. Ndlazi, Stacy Maddocks, Verusia Chetty, Sherika Hanley

Brief Report: Breast Milk Transfer and Infant Exposures to Dolutegravir, Tenofovir, and Tenofovir Alafenamide: Results From IMPAACT 2010/VESTED

JAIDS Journal of Acquired Immune Deficiency Syndromes(2025)10.1097/qai.0000000000003796
N/A
0DataRank · unranked
0 citations

Jung‐woo Chae, Lauren Ziemba, Anne Coletti, Kevin Knowles, Benjamin Johnston +21 more

Weight Changes and Adverse Pregnancy Outcomes With Dolutegravir- and Tenofovir Alafenamide Fumarate–Containing Antiretroviral Treatment Regimens During Pregnancy and Postpartum

Clinical Infectious Diseases(2024)10.1093/cid/ciae001
N/A
0DataRank · unranked
12 citations

Sean S. Brummel, Lauren Ziemba, Lameck Chinula, Katie McCarthy, Lee Fairlie +88 more

The Impact of Regular Screening and Lifestyle Modification on Cardiovascular Disease Risk Factors in South African Women Living With HIV

JAIDS Journal of Acquired Immune Deficiency Syndromes(2024)10.1097/qai.0000000000003387
N/A
0DataRank · unranked
3 citations

Dhayendre Moodley, Mergan Naidoo, Sean S. Brummel, Sherika Hanley

Unintended pregnancy and contraception use among African women living with HIV: Baseline analysis of the multi-country US PEPFAR PROMOTE cohort

UNC Libraries(2024)10.17615/4ehv-aj56
N/A
0DataRank · unranked
0 citations

Nonhlanhla Yende‐Zuma, Sufia Dadabhai, Taha E. Taha, Jim Aizire, Catherine Nakaye +5 more